Skip to main content
. 2023 Aug 21;15(16):4195. doi: 10.3390/cancers15164195

Table 1.

Study design.

Treatment Group Comments
Vehicle control
AZD6738, 12.5 mg/kg PO BID (14 days on, 14 days off) BID dosed 8 h apart
AZD6738, 25 mg/kg PO BID (14 days on, 14 days off) BID dosed 8 h apart
AZD7648, 100 mg/kg PO QD continuous
Olaparib, 100 mg/kg PO QD continuous
Olaparib, mono 100 mg/kg PO BID
AZD7648, 100 mg/kg PO QD continuous
AZD6738, 12.5 mg/kg PO BID (14 days on, 14 days off)
+ olaparib 100 mg/kg PO QD continuous
AZD6738 dosed 1 h after olaparib dose
AZD6738, 12.5 mg/kg PO BID (14 days on, 14 days off)
+ AZD7648, 100 mg/kg PO QD
AZD6738 dosed 1 h after AZD7648 dose
AZD7648, 100 mg/kg PO QD
+ olaparib, 100 mg/kg PO QD
Olaparib dosed 1 h after AZD7648 dose